APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tourette Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tourette Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchTourette Syndrome Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tourette Syndrome Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Tourette Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tourette Syndrome Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tourette Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Tourette Syndrome Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tourette Syndrome Drug include Teva Pharmaceutical Industries Ltd, Therapix Biosciences Ltd, Synchroneuron Inc, Reviva Pharmaceuticals Inc, Psyadon Pharmaceuticals Inc, Neurocrine Biosciences Inc, Catalyst Pharmaceuticals Inc and Abide Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tourette Syndrome Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tourette Syndrome Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tourette Syndrome Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tourette Syndrome Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Tourette Syndrome Drug Segment by Company

Teva Pharmaceutical Industries Ltd

Therapix Biosciences Ltd

Synchroneuron Inc

Reviva Pharmaceuticals Inc

Psyadon Pharmaceuticals Inc

Neurocrine Biosciences Inc

Catalyst Pharmaceuticals Inc

Abide Therapeutics Inc

Tourette Syndrome Drug Segment by Type

Ecopipam Hydrochloride

Dutetrabenazine ER

CPP-115

AZD-5213

Others

Tourette Syndrome Drug Segment by Application

Clinic

Hospital

Research Center

Others

Tourette Syndrome Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tourette Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tourette Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tourette Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tourette Syndrome Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tourette Syndrome Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tourette Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tourette Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tourette Syndrome Drug Industry Trends Table 2. Tourette Syndrome Drug Industry Drivers Table 3. Tourette Syndrome Drug Industry Opportunities and Challenges Table 4. Tourette Syndrome Drug Industry Restraints Table 5. Global Tourette Syndrome Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tourette Syndrome Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Tourette Syndrome Drug Sales Market Share by Manufacturers Table 9. Global Tourette Syndrome Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Tourette Syndrome Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tourette Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tourette Syndrome Drug Manufacturers, Product Type & Application Table 13. Global Tourette Syndrome Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tourette Syndrome Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ecopipam Hydrochloride Table 17. Major Manufacturers of Dutetrabenazine ER Table 18. Major Manufacturers of CPP-115 Table 19. Major Manufacturers of AZD-5213 Table 20. Major Manufacturers of Others Table 21. Global Tourette Syndrome Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 23. Global Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 24. Global Tourette Syndrome Drug Sales Market Share by Type (2021-2026) Table 25. Global Tourette Syndrome Drug Sales Market Share by Type (2027-2032) Table 26. Global Tourette Syndrome Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Tourette Syndrome Drug Revenue by Type (2021-2026) & (k units) Table 28. Global Tourette Syndrome Drug Revenue by Type (2027-2032) & (k units) Table 29. Global Tourette Syndrome Drug Revenue Market Share by Type (2021-2026) Table 30. Global Tourette Syndrome Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Research Center Table 34. Major Manufacturers of Others Table 35. Global Tourette Syndrome Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 37. Global Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 38. Global Tourette Syndrome Drug Sales Market Share by Application (2021-2026) Table 39. Global Tourette Syndrome Drug Sales Market Share by Application (2027-2032) Table 40. Global Tourette Syndrome Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Tourette Syndrome Drug Revenue by Application (2021-2026) & (k units) Table 42. Global Tourette Syndrome Drug Revenue by Application (2027-2032) & (k units) Table 43. Global Tourette Syndrome Drug Revenue Market Share by Application (2021-2026) Table 44. Global Tourette Syndrome Drug Revenue Market Share by Application (2027-2032) Table 45. Global Tourette Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Tourette Syndrome Drug Sales by Region (2021-2026) & (k units) Table 47. Global Tourette Syndrome Drug Sales Market Share by Region (2021-2026) Table 48. Global Tourette Syndrome Drug Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Tourette Syndrome Drug Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 52. North America Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 53. Europe Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 55. Europe Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 62. Global Tourette Syndrome Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Tourette Syndrome Drug Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Tourette Syndrome Drug Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Tourette Syndrome Drug Revenue Market Share by Region (2021-2026) Table 66. Global Tourette Syndrome Drug Revenue Market Share by Region (2027-2032) Table 67. Teva Pharmaceutical Industries Ltd Company Information Table 68. Teva Pharmaceutical Industries Ltd Business Overview Table 69. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio Table 71. Teva Pharmaceutical Industries Ltd Recent Development Table 72. Therapix Biosciences Ltd Company Information Table 73. Therapix Biosciences Ltd Business Overview Table 74. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio Table 76. Therapix Biosciences Ltd Recent Development Table 77. Synchroneuron Inc Company Information Table 78. Synchroneuron Inc Business Overview Table 79. Synchroneuron Inc Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Synchroneuron Inc Tourette Syndrome Drug Product Portfolio Table 81. Synchroneuron Inc Recent Development Table 82. Reviva Pharmaceuticals Inc Company Information Table 83. Reviva Pharmaceuticals Inc Business Overview Table 84. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 86. Reviva Pharmaceuticals Inc Recent Development Table 87. Psyadon Pharmaceuticals Inc Company Information Table 88. Psyadon Pharmaceuticals Inc Business Overview Table 89. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 91. Psyadon Pharmaceuticals Inc Recent Development Table 92. Neurocrine Biosciences Inc Company Information Table 93. Neurocrine Biosciences Inc Business Overview Table 94. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio Table 96. Neurocrine Biosciences Inc Recent Development Table 97. Catalyst Pharmaceuticals Inc Company Information Table 98. Catalyst Pharmaceuticals Inc Business Overview Table 99. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 101. Catalyst Pharmaceuticals Inc Recent Development Table 102. Abide Therapeutics Inc Company Information Table 103. Abide Therapeutics Inc Business Overview Table 104. Abide Therapeutics Inc Tourette Syndrome Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio Table 106. Abide Therapeutics Inc Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Tourette Syndrome Drug Distributors List Table 110. Tourette Syndrome Drug Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Tourette Syndrome Drug Product Image Figure 2. Global Tourette Syndrome Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tourette Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Tourette Syndrome Drug Sales (2021-2032) & (k units) Figure 5. Global Tourette Syndrome Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tourette Syndrome Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ecopipam Hydrochloride Image Figure 9. Dutetrabenazine ER Image Figure 10. CPP-115 Image Figure 11. AZD-5213 Image Figure 12. Others Image Figure 13. Global Tourette Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Tourette Syndrome Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tourette Syndrome Drug Sales Market Share by Type (2021-2032) Figure 16. Global Tourette Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Tourette Syndrome Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Tourette Syndrome Drug Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Research Center Image Figure 22. Others Image Figure 23. Global Tourette Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Tourette Syndrome Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Tourette Syndrome Drug Sales Market Share by Application (2021-2032) Figure 26. Global Tourette Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Tourette Syndrome Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Tourette Syndrome Drug Revenue Market Share by Application (2021-2032) Figure 29. North America Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Tourette Syndrome Drug Sales Market Share by Country (2021-2032) Figure 31. U.S. Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Tourette Syndrome Drug Sales Market Share by Country (2021-2032) Figure 36. Germany Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Tourette Syndrome Drug Sales Market Share by Country (2021-2032) Figure 43. China Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country (2021-2032) Figure 51. Brazil Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Tourette Syndrome Drug Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Tourette Syndrome Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Tourette Syndrome Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 62. North America Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 64. Europe Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Tourette Syndrome Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Tourette Syndrome Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Ecopipam Hydrochloride
  • Dutetrabenazine ER
  • CPP-115
  • AZD-5213
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Therapix Biosciences Ltd
  • Synchroneuron Inc
  • Reviva Pharmaceuticals Inc
  • Psyadon Pharmaceuticals Inc
  • Neurocrine Biosciences Inc
  • Catalyst Pharmaceuticals Inc
  • Abide Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tourette Syndrome Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tourette Syndrome Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tourette Syndrome Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tourette Syndrome Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tourette Syndrome Drug Market Dynamics
  1. 2.1 Tourette Syndrome Drug Industry Trends
  2. 2.2 Tourette Syndrome Drug Industry Drivers
  3. 2.3 Tourette Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Tourette Syndrome Drug Industry Restraints
3 Tourette Syndrome Drug Market by Manufacturers
  1. 3.1 Global Tourette Syndrome Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tourette Syndrome Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tourette Syndrome Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tourette Syndrome Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tourette Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tourette Syndrome Drug Manufacturers, Product Type & Application
  7. 3.7 Global Tourette Syndrome Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tourette Syndrome Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tourette Syndrome Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tourette Syndrome Drug Tier 1, Tier 2, and Tier 3
4 Tourette Syndrome Drug Market by Type
  1. 4.1 Tourette Syndrome Drug Type Introduction
  2. 4.1.1 Ecopipam Hydrochloride
  3. 4.1.2 Dutetrabenazine ER
  4. 4.1.3 CPP-115
  5. 4.1.4 AZD-5213
  6. 4.1.5 Others
  7. 4.2 Global Tourette Syndrome Drug Sales by Type
  8. 4.2.1 Global Tourette Syndrome Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Tourette Syndrome Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Tourette Syndrome Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Tourette Syndrome Drug Revenue by Type
  12. 4.3.1 Global Tourette Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Tourette Syndrome Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Tourette Syndrome Drug Revenue Market Share by Type (2021-2032)
5 Tourette Syndrome Drug Market by Application
  1. 5.1 Tourette Syndrome Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research Center
  5. 5.1.4 Others
  6. 5.2 Global Tourette Syndrome Drug Sales by Application
  7. 5.2.1 Global Tourette Syndrome Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tourette Syndrome Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Tourette Syndrome Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Tourette Syndrome Drug Revenue by Application
  11. 5.3.1 Global Tourette Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tourette Syndrome Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Tourette Syndrome Drug Revenue Market Share by Application (2021-2032)
6 Global Tourette Syndrome Drug Sales by Region
  1. 6.1 Global Tourette Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tourette Syndrome Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Tourette Syndrome Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Tourette Syndrome Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tourette Syndrome Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tourette Syndrome Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tourette Syndrome Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tourette Syndrome Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tourette Syndrome Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tourette Syndrome Drug Revenue by Region
  1. 7.1 Global Tourette Syndrome Drug Revenue by Region
  2. 7.1.1 Global Tourette Syndrome Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tourette Syndrome Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Tourette Syndrome Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Tourette Syndrome Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tourette Syndrome Drug Revenue (2021-2032)
  8. 7.2.2 North America Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tourette Syndrome Drug Revenue (2021-2032)
  11. 7.3.2 Europe Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tourette Syndrome Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tourette Syndrome Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tourette Syndrome Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd
  2. 8.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 8.2 Therapix Biosciences Ltd
  8. 8.2.1 Therapix Biosciences Ltd Company Information
  9. 8.2.2 Therapix Biosciences Ltd Business Overview
  10. 8.2.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio
  12. 8.2.5 Therapix Biosciences Ltd Recent Developments
  13. 8.3 Synchroneuron Inc
  14. 8.3.1 Synchroneuron Inc Company Information
  15. 8.3.2 Synchroneuron Inc Business Overview
  16. 8.3.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Synchroneuron Inc Tourette Syndrome Drug Product Portfolio
  18. 8.3.5 Synchroneuron Inc Recent Developments
  19. 8.4 Reviva Pharmaceuticals Inc
  20. 8.4.1 Reviva Pharmaceuticals Inc Company Information
  21. 8.4.2 Reviva Pharmaceuticals Inc Business Overview
  22. 8.4.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  24. 8.4.5 Reviva Pharmaceuticals Inc Recent Developments
  25. 8.5 Psyadon Pharmaceuticals Inc
  26. 8.5.1 Psyadon Pharmaceuticals Inc Company Information
  27. 8.5.2 Psyadon Pharmaceuticals Inc Business Overview
  28. 8.5.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  30. 8.5.5 Psyadon Pharmaceuticals Inc Recent Developments
  31. 8.6 Neurocrine Biosciences Inc
  32. 8.6.1 Neurocrine Biosciences Inc Company Information
  33. 8.6.2 Neurocrine Biosciences Inc Business Overview
  34. 8.6.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio
  36. 8.6.5 Neurocrine Biosciences Inc Recent Developments
  37. 8.7 Catalyst Pharmaceuticals Inc
  38. 8.7.1 Catalyst Pharmaceuticals Inc Company Information
  39. 8.7.2 Catalyst Pharmaceuticals Inc Business Overview
  40. 8.7.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  42. 8.7.5 Catalyst Pharmaceuticals Inc Recent Developments
  43. 8.8 Abide Therapeutics Inc
  44. 8.8.1 Abide Therapeutics Inc Company Information
  45. 8.8.2 Abide Therapeutics Inc Business Overview
  46. 8.8.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio
  48. 8.8.5 Abide Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tourette Syndrome Drug Value Chain Analysis
  2. 9.1.1 Tourette Syndrome Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tourette Syndrome Drug Production Mode & Process
  6. 9.2 Tourette Syndrome Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tourette Syndrome Drug Distributors
  9. 9.2.3 Tourette Syndrome Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst